Related Experiment Video
Updated: Jan 7, 2026

Analyzing Long-Term Electrocardiography Recordings to Detect Arrhythmias in Mice
Published on: May 23, 2021
Deep Learning-Based Continuous QT Monitoring to Identify High-Risk Prolongation Events After Class III Antiarrhythmic
Rayan A Ansari1,2, Sabyasachi Bandyopadhyay1,3, Rishi K Trivedi4
1Department of Medicine (R.A.A., S.B., K.A.B., X.L., P.G., A.C.P., E.A.A., P.J.W., M.V.P., S.M.N., A.J.R.), Stanford University, CA.
A novel deep learning system, 3DRECON-QT, accurately quantifies QT/QTc from single-lead ECGs, enabling continuous monitoring for high-risk drug-induced QT prolongation. This technology identifies patients at increased risk of ventricular arrhythmias.
Area of Science:
- Cardiology
- Medical Technology
- Artificial Intelligence in Medicine
Background:
- Drug-induced QT prolongation is a risk during outpatient care for patients on Class III antiarrhythmics.
- Insertable cardiac monitors provide continuous data but are limited to single-lead configurations.
- Accurate QT/QTc measurement is crucial for managing antiarrhythmic drug safety.
Purpose of the Study:
- To develop and validate a deep learning system (3DRECON-QT) for reconstructing spatial information from single-lead ECGs.
- To quantify QT/QTc intervals and identify high-risk QT prolongation using this system.
- To assess the system's performance in continuous monitoring and real-world outpatient cohorts.
Main Methods:
- Developed 3DRECON-QT, a multitask encoder-decoder model, to ingest single-lead ECGs and predict 12-lead ECGs and QT/QTc.
- Trained and tested the model on large health system and external center datasets, including a public dofetilide-loading dataset.
- Validated performance in a real-world cohort of outpatients on dofetilide or sotalol and in patients with insertable cardiac monitor recordings.
Main Results:
- 3DRECON-QT achieved high accuracy in classifying prolonged QTc (AUC 0.942 internal, 0.943 external) with low mean absolute error.
- Continuous monitoring predictions correlated well with ground truth (r=0.851) and accurately identified QTc changes.
- In outpatients, 16.5% showed high-risk QTc prolongation, associated with a 4.24-fold increased risk of ventricular arrhythmias detected by 3DRECON-QT (AUC 0.94).
Conclusions:
- A single-lead deep learning approach can achieve guideline-level QT/QTc measurement accuracy.
- Enables continuous QTc surveillance from nonstandard ECG vectors, enhancing safety monitoring for Class III antiarrhythmics.
- Identifies clinically meaningful outpatient QTc prolongation linked to a significantly higher risk of serious ventricular arrhythmias.
More Related Videos
Related Concept Videos
Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers
Pulse rhythm
Conversely, an irregular pulse pattern is termed dysrhythmia, stemming from disruptions in cardiac...
Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
Antiarrhythmic Drugs: Class II Agents as β-Adrenergic Blockers
Dysrhythmias VII: Nursing Management of Dysrhythmias
Antiarrhythmic Drugs: Class IV Agents as Calcium Channel Blockers
Verapamil, a calcium channel blocker, inhibits calcium movement across myocardial cell membranes and vascular smooth muscle. This results in the dilation of coronary and...

